Kenvue Inc. $KVUE Holdings Lifted by Equity Investment Corp

Equity Investment Corp increased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 32.1% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 6,820,350 shares of the company’s stock after purchasing an additional 1,655,417 shares during the quarter. Kenvue makes up 2.4% of Equity Investment Corp’s investment portfolio, making the stock its 13th largest position. Equity Investment Corp’s holdings in Kenvue were worth $117,651,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Physician Wealth Advisors Inc. grew its holdings in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after buying an additional 618 shares in the last quarter. Elyxium Wealth LLC purchased a new position in shares of Kenvue during the fourth quarter valued at $26,000. SBI Securities Co. Ltd. grew its holdings in shares of Kenvue by 82.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after buying an additional 1,027 shares in the last quarter. Leonteq Securities AG purchased a new position in shares of Kenvue during the fourth quarter valued at $45,000. Finally, Hantz Financial Services Inc. grew its holdings in shares of Kenvue by 157.2% during the third quarter. Hantz Financial Services Inc. now owns 2,850 shares of the company’s stock valued at $46,000 after buying an additional 1,742 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 1.59% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Citigroup lowered their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Canaccord Genuity Group lifted their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Wednesday, February 18th. Barclays reduced their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. Finally, Weiss Ratings cut Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.33.

Kenvue Price Performance

KVUE opened at $18.08 on Friday. The stock has a market cap of $34.70 billion, a price-to-earnings ratio of 21.26, a PEG ratio of 1.37 and a beta of 0.54. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a fifty day moving average price of $17.41 and a 200 day moving average price of $17.53.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. During the same quarter last year, the firm earned $0.24 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. Analysts forecast that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.6%. Kenvue’s payout ratio is currently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.